COMMUNIQUÉS West-GlobeNewswire

Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
20/10/2025
Using AI and a smartphone camera, Noom makes personalized health screening and motivational tools accessible to all for free Noom’s free Face Scan feature PRINCETON, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Noom , the [...]
Anresco Laboratories and NJ Labs Unite to Form Nationwide Testing Network Built on Trusted, Proven Expertise
20/10/2025
LAS VEGAS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Anresco Laboratories and NJ Labs —two of the nation’s most established analytical laboratories—have joined forces to establish Anresco NJ Labs , a nationwide network uniting [...]
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
20/10/2025
NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will [...]
Oncotelic to Present at the LD Micro Main Event XIX
20/10/2025
AGOURA HILLS, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat cancer [...]
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
20/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary [...]
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
20/10/2025
HORSHAM, Penn., Oct. 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
20/10/2025
Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS) Prolonged tumor control with increasing doses of BA3182; confirmed partial response (cPR) at 0.6 mg in a [...]
MBX Biosciences to Participate in November Investor Conferences
20/10/2025
CARMEL, Ind., Oct. 20, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance
20/10/2025
WESTBROOK, Maine, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with Atlantic Importing Company [...]
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
20/10/2025
Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company [...]
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
20/10/2025
In vivo studies demonstrate robust and durable gene silencing across rodents and non-human primates Megalin-targeting ligand-siRNA conjugates (megalin-STRIKERs) deliver siRNAs to proximal tubular epithelial cells (PTECs [...]
Certara Scientists are Among the Topmost Cited Biopharma Researchers
20/10/2025
Certara celebrates its 200 published papers and 11 scientists on Stanford/Elsevier top 2% cited researchers list in 2025 RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in [...]
Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD
20/10/2025
Preclinical results support 6-month dosing, demonstrating VLTR-559’s substantially longer ocular half-life, with high drug concentrations retained in the retina compared to current anti-VEGF standard of care VLTR-559 [...]
Connect Expands Access to Funding Through Curated Venture List
20/10/2025
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Connect , a premier nonprofit organization in San Diego’s innovation ecosystem dedicated to supporting entrepreneurs and cultivating thriving life science and technology [...]
Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring
20/10/2025
MENLO PARK, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Adaptyx Biosciences , a biowearables company developing the first platform for continuous, multi-analyte molecular monitoring, today announced it has raised $14 [...]
CervoMed to Present at the Emerging Growth Conference
20/10/2025
BOSTON, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that [...]
Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025
20/10/2025
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, today announced that new preclinical data from its ACT-UP1 [...]
Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025
20/10/2025
Management to host conference call on Thursday, October 30, 2025, at 8:00 am EDT FLORHAM PARK, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on [...]
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
20/10/2025
Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “ [...]

Pages